Psoriasis at IDC 2027

Psoriasis is a chronic skin disorder that affects of an estimated 2-3% of the general population. It is characterized by the presence of red, scaly lesions on the skin, typically on the elbows, knees, hands, scalp, and torso, but can occur anywhere. It is caused by an abnormal immune response, in which the immune system mistakenly attacks the skin cells as if they were foreign invaders. This results in an accelerated growth of skin cells, which build up on the surface of the skin, forming raised lesions with silvery scales. Treatment of psoriasis can include topical and systemic drug therapies, phototherapy, and lifestyle modifications. Topical treatments, such as corticosteroids and retinoids, are typically used to address mild cases of psoriasis, while systemic treatments, such as methotrexate and cyclosporine, are better suited for more severe cases. Phototherapy makes use of ultraviolet light to reduce inflammation and slow cell turnover. Lastly, lifestyle modifications, such as avoiding triggers, keeping skin hydrated, and managing stress, can help to improve psoriasis symptoms. Although there is currently no cure for psoriasis, there are ways to manage the condition and keep it under control. It is important to be proactive and follow the advice of a healthcare provider when managing psoriasis. Working together with a healthcare provider can help to determine the best possible treatment course to manage symptoms and improve overall quality of life.